InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,218.09
(
0.08%
)
US TECH 100
17,657.20
(
0.09%
)
Dow Jones
39,481.66
(
0.24%
)
Brent Oil
82.70
(
-1.49%
)
Bitcoin
60,316.01
(
-4.33%
)
Post# of 205
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jfk

Send PM Follow Ignore
Followers 4
Posts 380
Boards Moderated 0
Alias Born 05/10/2007

jfk

Re: None

Friday, 08/27/2021 11:28:19 AM

Friday, August 27, 2021 11:28:19 AM

Post# of 205
today:
Avenue Therapeutics, Inc. (“Avenue”), received an Appeal Denied Letter from the Office of Neuroscience of the FDA in Response to its Formal Dispute Resolution Request
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent FBIO News
More FBIO News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!